Keywords: sumitomo, pharma, profits, down, sharply, japan, pharmaceuticals
Sumitomo Pharma Profits Down Sharply
Article | 20 March 1995
Japan's Sumitomo Pharmaceuticals reported a 7.8% downturn in sales for the fiscal year ended December 31, 1994, at 220.36 billion yen ($3.38 billion), largely as ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- Neovacs moving forward in rheumatoid arthritis, say analysts
